secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001628280-26-003842
Event type: litigation
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud

Amneal Pharmaceuticals makes effective opioid settlement with states and subdivisions
--------------------------------------------------------------------------------

- Amneal determined to make effective its Nationwide Opioids Settlement Agreement on Jan 29, 2026, with sufficient state and subdivision participation.
- Company will pay $88.5 million to participating states and subdivisions.
- Company will provide up to $177.4 million in naloxone nasal spray (valued at $125 per twin pack) to treat opioid overdoses.
- Settling parties can opt for cash up to $44.4 million (25% of product value) during last four years of ten-year term, potentially raising total cash to $132.9 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000162828026003842/0001628280-26-003842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000162828026003842/amrx-20260123.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-003842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer